SUPN Stock Ownership Activity

SUPERNUS PHARMACEUTICALS INC 13F holders

1 value investing guru has made changes to the SUPERNUS PHARMACEUTICALS INC (SUPN) position according to the gurus' latest SEC quarterly report(s). The number of SUPN shares has been increased by 1 super investor(s).

Which gurus or hedge funds are buying SUPN now?

According to the latest SEC filing(s) SUPERNUS PHARMACEUTICALS INC (SUPN) has been bought by Marty Whitman - Third Avenue Management (added shares +0.2%).

To see more about who is investing in SUPERNUS PHARMACEUTICALS INC (SUPN), please go to the SUPN ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2024 Q3 (1 result)
Marty Whitman
Third Avenue Management
+0.20%
+375
+0.00%
0.97%
Current price: $35.57 14.08% Reported price*: $31.18
2024 Q2 (1 result)
Marty Whitman
Third Avenue Management
+18.41%
+29,401
+0.13%
0.87%
Current price: $35.57 32.97% Reported price*: $26.75
2023 Q4 (1 result)
Marty Whitman
Third Avenue Management
+37.04%
+43,168
+0.21%
0.76%
Current price: $35.57 22.91% Reported price*: $28.94
2023 Q3 (1 result)
Marty Whitman
Third Avenue Management
+73.79%
+49,487
+0.23%
0.55%
Current price: $35.57 26.67% Reported price*: $28.08
2023 Q2 (1 result)
Marty Whitman
Third Avenue Management
+2,626.10%
+64,602
+0.32%
0.33%
Current price: $35.57 18.33% Reported price*: $30.06
2022 Q2 (1 result)
Marty Whitman
Third Avenue Management
buy
+1,303
+0.01%
0.01%
Current price: $35.57 21.46% Reported price*: $29.29
6 of 6

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.